The collaboration leverages AMNM’s established clinical network in Lusail to facilitate the deployment of OxiWear’s measurement devices. By combining OxiWear’s specialized hardware with the local expertise of a facility affiliated with the Chicago-based Northwestern Medicine system, the partners intend to accelerate market development and patient engagement throughout the region.

Shavini Fernando, founder and CEO of OxiWear, emphasized that securing a partner with a deep understanding of the local ecosystem is critical to the company’s international growth. Dr. Abdulla Al-Ansari, CEO of AMNM, noted that the integration of these physiological monitoring tools aligns with the center’s ongoing mission to introduce advanced medical technologies to Qatar’s healthcare sector. The organizations will now focus on a joint strategy encompassing distribution channels and clinical application development.